★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated · archived quarter

Glenview Capital

Larry Robbins (CEO) · New York, NY · CIK 1138995 · EDGAR filings ↗

Healthcare-heavy fundamental manager.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$3.98BReported 13F value
44Positions
63.6%Top-10 weight
15.90Effective holdings
11.5%Est. turnover
+6New
−18Exits

Reported 13F portfolio value covers U.S. reportable long positions only, not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Healthcare 48.8% (-1.7pp)
Technology 20.7% (+1.1pp)
Financial Services 11.6% (+1.8pp)
Consumer Cyclical 10.6% (+0.5pp)
Communication Services 3.8% (+1.5pp)
Basic Materials 1.5% (-0.5pp)
Industrials 1.2% (-1.8pp)
Consumer Defensive 1.2% (-0.6pp)
Energy 0.5% (+0.4pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q1 2026
#SecurityWeightValueSharesΔ sharesHeld
1 CVS CVS Health Corp. 15.9% $588.69M 8.20M 0.0% Held 8
2 GPN Global Payments Inc. 11.6% $428.05M 6.36M +7.4% ▲ Add 8
3 THC Tenet Healthcare Corporation 7.8% $287.76M 1.52M -23.1% ▼ Trim 8
4 AMZN Amazon.com, Inc. 6.0% $220.61M 1.06M +16.5% ▲ Add 8
5 TEVA Teva Pharmaceutical… 5.4% $200.61M 6.66M -60.2% ▼ Trim 8
6 CI Cigna Corporation 3.6% $133.07M 498.84K +78.6% ▲ Add 8
7 AMD Advanced Micro Devices, Inc. 3.6% $132.39M 650.79K +65.1% ▲ Add 2
8 TMO Thermo Fisher Scientific… 3.3% $123.14M 250.53K +11.9% ▲ Add 4
9 VTRS Viatris Inc. 3.3% $122.77M 9.09M -18.0% ▼ Trim 8
10 DXC DXC Technology Company 3.0% $111.82M 8.90M +7.0% ▲ Add 8
11 CNC Centene Corp. 2.8% $105.21M 3.21M +73.2% ▲ Add 3
12 UBER Uber Technologies, Inc. 2.8% $104.72M 1.46M +105.7% ▲ Add 8
13 GTM ZoomInfo Technologies Inc. 2.6% $95.11M 15.91M -20.5% ▼ Trim 8
14 XYZ Block, Inc. 2.2% $82.11M 1.36M +60.2% ▲ Add 3
15 META Meta Platforms, Inc. 1.9% $70.18M 122.66K +960.0% ▲ Add 5
16 AMAT Applied Materials, Inc. 1.8% $67.40M 197.21K +52.1% ▲ Add 2
17 ONTO Onto Innovation Inc. 1.7% $61.46M 299.72K -27.8% ▼ Trim 3
18 DKS DICK'S Sporting Goods, Inc. 1.6% $59.27M 298.91K +5.3% ▲ Add 4
19 HUM Humana Inc. 1.6% $58.07M 334.89K New New 1
20 BFLY Butterfly Network, Inc. 1.6% $57.91M 14.34M -10.7% ▼ Trim 8
21 ESI Element Solutions Inc 1.5% $55.60M 1.63M -42.5% ▼ Trim 8
22 UAL United Airlines Holdings… 1.2% $45.75M 496.86K -2.8% ▼ Trim 5
23 EYE National Vision Holdings… 1.1% $40.56M 1.57M +9.6% ▲ Add 4
24 FUN Six Flags Entertainment… 1.1% $39.46M 2.22M +98.1% ▲ Add 2
25 GENI Genius Sports Limited 1.0% $37.92M 8.56M +321.7% ▲ Add 2
26 USFD US Foods Holding Corp. 1.0% $35.41M 384.01K -66.2% ▼ Trim 8
27 Z Zillow Group, Inc. Class C 0.9% $32.68M 789.67K -32.1% ▼ Trim 3
28 LAD Lithia Motors, Inc. 0.9% $31.87M 127.61K 0.0% Held 3
29 BLCO Bausch + Lomb Corporation 0.8% $30.38M 1.91M +15.5% ▲ Add 5
30 DHR Danaher Corporation 0.8% $29.63M 156.28K -21.9% ▼ Trim 4
31 LION Lionsgate Studios Corp. 0.7% $26.65M 2.78M -63.0% ▼ Trim 3
32 CSCO Cisco Systems, Inc. 0.7% $26.37M 339.82K New New 1
33 MYGN Myriad Genetics, Inc. 0.7% $24.35M 5.41M +18.0% ▲ Add 8
34 SGRY Surgery Partners, Inc. 0.6% $21.46M 1.80M -53.3% ▼ Trim 4
35 DOCN DigitalOcean Holdings, Inc. 0.6% $21.45M 250.00K -87.5% ▼ Trim 2
36 BKR Baker Hughes Company 0.5% $18.54M 303.68K New New 1
37 AKAM Akamai Technologies, Inc. 0.5% $17.97M 156.45K New New 1
38 INTC Intel Corp. 0.5% $17.63M 399.51K New New 1
39 BIIB Biogen Inc. 0.3% $10.45M 57.02K -80.4% ▼ Trim 2
40 PRMB Primo Brands Corporation 0.3% $10.00M 531.05K New New 1
41 TECH Bio-Techne Corporation 0.3% $9.74M 186.31K -70.0% ▼ Trim 3

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
60–1 quarters
182–4 quarters
175–8 quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Holocene Advisors, LP 24 3.0% 0.2532 Compare ⇄
Dodge & Cox 16 6.5% 0.2039 Compare ⇄
Appaloosa 4 6.3% 0.2021 Compare ⇄
Parnassus Investments, Llc 13 7.9% 0.1892 Compare ⇄
Point72 Asset Management 32 1.7% 0.1872 Compare ⇄
Grantham, Mayo, Van Otterloo & Co. LLC 21 3.1% 0.1843 Compare ⇄
Tiger Global Management 7 8.6% 0.1769 Compare ⇄
Boston Partners 26 3.2% 0.1752 Compare ⇄

Similarity of reported longs only; hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$5.49B · 45 holdings listed · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$3.98B · 44 holdings listed · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$4.91B · 57 holdings listed · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$4.49B · 54 holdings listed · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$3.57B · 43 holdings listed · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$4.07B · 45 holdings listed · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$3.96B · 36 holdings listed · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$5.17B · 46 holdings listed · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$5.08B · 48 holdings listed · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q1 2026 · latest filing Aug 14, 2026 · Change methodology